Amicus Therapeutics Inc (FOLD)
9.17
-0.30
(-3.17%)
USD |
NASDAQ |
May 10, 12:48
Amicus Therapeutics Price: 9.17 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 09, 2024 | 9.97 | 10.00 | 9.24 | 9.47 | 5.784M |
May 08, 2024 | 10.26 | 10.38 | 10.10 | 10.14 | 2.242M |
May 07, 2024 | 10.40 | 10.57 | 10.26 | 10.42 | 2.876M |
May 06, 2024 | 10.39 | 10.46 | 10.29 | 10.34 | 1.084M |
May 03, 2024 | 10.74 | 10.79 | 10.36 | 10.40 | 1.379M |
May 02, 2024 | 10.51 | 10.61 | 10.36 | 10.43 | 2.577M |
May 01, 2024 | 10.09 | 10.60 | 9.975 | 10.43 | 3.980M |
Apr 30, 2024 | 10.17 | 10.23 | 9.96 | 9.99 | 2.347M |
Apr 29, 2024 | 10.38 | 10.52 | 10.24 | 10.25 | 1.956M |
Apr 26, 2024 | 10.26 | 10.32 | 10.11 | 10.28 | 1.715M |
Apr 25, 2024 | 10.40 | 10.47 | 10.02 | 10.17 | 4.003M |
Apr 24, 2024 | 10.71 | 10.78 | 10.50 | 10.54 | 1.821M |
Apr 23, 2024 | 10.82 | 10.93 | 10.68 | 10.71 | 5.091M |
Apr 22, 2024 | 10.70 | 10.91 | 10.66 | 10.82 | 4.621M |
Apr 19, 2024 | 10.27 | 10.66 | 10.24 | 10.61 | 2.888M |
Apr 18, 2024 | 10.56 | 10.59 | 10.32 | 10.33 | 1.726M |
Apr 17, 2024 | 10.61 | 10.66 | 10.48 | 10.55 | 3.013M |
Apr 16, 2024 | 10.61 | 10.72 | 10.48 | 10.56 | 2.800M |
Apr 15, 2024 | 10.66 | 10.81 | 10.59 | 10.66 | 2.751M |
Apr 12, 2024 | 11.07 | 11.07 | 10.56 | 10.68 | 2.248M |
Apr 11, 2024 | 11.33 | 11.41 | 11.15 | 11.22 | 1.693M |
Apr 10, 2024 | 11.36 | 11.46 | 11.14 | 11.27 | 2.453M |
Apr 09, 2024 | 11.60 | 11.77 | 11.49 | 11.75 | 2.083M |
Apr 08, 2024 | 11.69 | 11.82 | 11.50 | 11.60 | 1.542M |
Apr 05, 2024 | 11.37 | 11.78 | 11.21 | 11.72 | 2.738M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.23
Minimum
May 09 2022
24.89
Maximum
Dec 22 2020
11.80
Average
11.26
Median
Jun 03 2019
Price Benchmarks
TG Therapeutics Inc | 16.70 |
Geron Corp | 3.795 |
Vanda Pharmaceuticals Inc | 4.96 |
Fate Therapeutics Inc | 4.13 |
Editas Medicine Inc | 5.37 |
Price Related Metrics
PS Ratio | 6.777 |
Price to Book Value | 16.91 |
Earnings Yield | -5.56% |
Market Cap | 2.709B |